Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Adeno-Associated Viral (AAV) Vector Market Industry Trends and Global Forecasts to 2035: Distribution by Type of Therapy, Therapeutic Area, Route of ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
An R75W mutation in the gap junction β2 (GJB2) gene causes severe fragmentation of gap junction plaques, connecting adjacent cells and leading to syndromic hearing loss. In a new experimental study, ...
A new study characterizes a bioengineered adeno-associated virus (AAV)3B capsid variant that demonstrates improved transduction to human liver cells. Another advantage of the AAV3B-V04 capsid was its ...
Duchenne muscular dystrophy is a severe, progressive, X-linked neuromuscular disease affecting approximately one in 5,000 male births. It is caused by mutations in the DMD gene that prevent the ...
NEW YORK & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apertura Gene Therapy, a biotechnology company opening opportunities in genetic medicine for treating debilitating diseases with limited options, today ...
Manufacturing activities are expected to include process optimization, scale-up, analytical qualification, and potency assay ...
Discover how automated purification workflows can increase throughput, improve reproducibility, and simplify protein, antibody, and AAV sample preparation across research and discovery applications.
Andelyn Biosciences to scale manufacturing for Genprex’s diabetes gene therapy programme: Columbus, Ohio Thursday, September 3, 2026, 16:00 Hrs [IST] Andelyn Biosciences, a lead ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results